Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P120: Usefulness of the faecal calprotectin for the diagnosis of inflammatory bowel disease in patients with spondylorarthritis and no digestive symptoms

ECCO '19 Copenhagen

Year: 2019
Authors:

Y. González-Lama1, V. Matallana1, M. Calvo1, M. Espinosa2, C. Ramos2, C. Merino2, B. Ruiz-Antorán3, I. González-Partida1, M. I. Vera1, J. Sanz2

1IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain, 2Rheumatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain, 3Clinical Pharmacology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain

P121: Correlation between histological activity and endoscopy in patients with UC, seen in a tertiary centre of gastroenterology in Romania

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Cojocaru*1, C. Gheorghe2, L. Gheorghe2

1Center for Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Gastroenterology, Bucharest, Romania, 2Center for Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania

P122: Longitudinal follow-up of body mass index as a predictor for severe disease course in children with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Yerushalmy-Feler*1,2, S. Cohen1,2

1Tel Aviv Sourasky Medical Center, Pediatric Gastroenterology, Tel Aviv, Israel, 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

P123: The fully-automated LIAISON Calprotectin immunoassay from DiaSorin can distinguish between IBD and IBS patients

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Vicente Steijn*1, J. M. Jansen2, R. Bisheshar1, M. Romeijn1, I-A. Haagen1

1OLVG Lab BV, Laboratory of Hematology and Clinical Chemistry, Amsterdam, The Netherlands, 2OLVG Oost, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

P124: Latent and active tuberculosis in patients with inflammatory bowel disease under anti-TNF—data from a centre with high incidence of tuberculosis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Sousa*1, I. Ladeira1, C. Fernandes1, A. Ponte1, A. Rodrigues1, A. P. Silva1, J. Rodrigues1, J. Silva1, C. Gomes1, J. Carvalho1

1Centro Hospitalar de Vila Nova de Gaia e Espinho, Vila Nova de Gaia, Portugal

P125: Role of UCEIS vs. MES in predicting patients unresponsive to biological therapy and need for surgery: a retrospective single-centre analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Variola*1, M. Di Ruscio1, G. Barugola2, G. Lunardi3, A. Massella4, P. Bocus4, A. Geccherle1

1IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2IRCCS Sacro Cuore Don Calabria, General Surgery, Negrar, Italy, 3IRCCS Sacro Cuore Don Calabria, Division of Medical Oncology, Negrar, Italy, 4IRCCS Sacro Cuore Don Calabria, Gastroenterology, Negrar, Italy

P126: Low reproductive knowledge and fertility in patients with inflammatory bowel disease in Serbia—results of pilot study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Glisic*1, A. Sokic-Milutinovic1, S. Zgradic1, I. Jovicic1

1Clinic for Gastroenterology and Hepatology, Belgrade, Serbia

P127: Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Bastida*1,2, I. Marín-Jiménez3,4, A. Forés5, E. García-Planella6, F. Argüelles-Arias7, P. Sarasa8, I. Tagarro8, A. Fernández-Nistal8, C. Montoto8, M. Aguas1,2, J. Santos-Fernández9, M. Boscá10, R. Ferreiro-Iglesias11, O. Merino12, X. Aldeguer13, X. Cortés14,15, B. Sicilia16, F. Mesonero17, M. Barreiro-de Acosta11

1Hospital La Fe, Valencia, Spain, 2Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Valencia, Spain, 3Hospital Gregorio Marañón, Department of Gastroenterology, Madrid, Spain, 4Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain, 5Hospital General Universitario de Castellón, Castellón, Spain, 6Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 7Hospital Universitario Virgen Macarena, Sevilla, Spain, 8Takeda Farmacéutica España SA, Madrid, Spain, 9Hospital Universitario Río Hortega, Department of Gastroenterology, Valladolid, Spain, 10University Clinic Hospital of Valencia, IBD Unit, Gastroenterology Department, Valencia, Spain, 11Hospital Clínico Universitario de Santiago, Department of Gastroenterology, Santiago de Compostela, Spain, 12Hospital Universitario Cruces, Department of Gastroenterology, Bilbao, Spain, 13Hospital Dr. Josep Trueta, Department of Gastroenterology, Girona, Spain, 14Hospital de Sagunto, IBD Unit, Gastroenterology Section, Sagunto, Spain, 15University of Cardenal Herrera-CEU, Castellón, Spain, 16Hospital Universitario de Burgos, Burgos, Spain, 17Hospital Ramón y Cajal, Department of Gastroenterology, Madrid, Spain

P128: Histological activity predicts clinical relapse in patients with ulcerative colitis in endoscopic remission

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Laterza*1, A. C. Piscaglia2, S. Bibbò1, V. Arena3, M. Brisigotti4, G. Fabbretti4, M. L. Stefanelli2, E. Gaetani1, V. Cesario2, G. Cammarota1, A. Armuzzi5, F. Scaldaferri1, A. Gasbarrini1

1Fondazione Policlinico A. Gemelli IRCCS, Internal Medicine and Gastroenterology, Rome, Italy, 2State Hospital, Gastroenterology and Endoscopy Unit, Borgo Maggiore, San Marino, 3Fondazione Policlinico A. Gemelli IRCCS, Instiute of Pathology, Rome, Italy, 4Infermi Hospital, Institute of Pathology, Rimini, Italy, 5Fondazione Policlinico A. Gemelli IRCCS, Presidio Columbus, Rome, Italy

P129: Endoscopy and inflammatory bowel disease: data from a pilot experience to investigate the gap between the current guidelines and the real clinical practice

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Mocciaro*1, B. Magro1, E. Conte1, A. Bonaccorso1, D. Scimeca1, R. Di Mitri1

1Gastroenterology and Endoscopy Unit, ARNAS Civico-Di Cristina-Benfratelli Hospital, Palermo, Italy

P130: Delay in diagnosis of inflammatory bowel diseases and associated factors since the 1980s

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Giannelis1, G. Michalopoulos*1, S. Vrakas1, K. Makris1, C. Kapizioni1, P. Kourkoulis1, G. Koutoufaris1, K. Milioni1, V. Xourgias1

1Tzaneion General Hospital of Piraeus, Gastroenterology, Piraeus, Greece

P131: Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry

ECCO '19 Copenhagen

Year: 2019
Authors:

E. Louis*1, V. Muls2, P. Bossuyt3, A. Colard4, A. Nakad5, D. Baert6, F. Mana7, P. Caenepeel8, S. Vanden Branden9, S. Vermeire10, F. D’Heygere11, B. Strubbe12, A. Cremer13, J-C. Coche14, V. Setakhr15, F. Baert16, A. Vijverman17, J. L. Coenegrachts18, F. Flamme19, A. Hantson20, K. Wijnen20, E. Piters20, G. Hantsbarger21, F. Wan21, B. Jiang21, P. Dolin22

1University Hospital CHU of Liège, Liege, Belgium, 2Saint-Pierre University Hospital,, Brussels, Belgium, 3Imeldaziekenhuis, Bonheiden, Belgium, 4Hospital CHC, Liège, Belgium, 5CHwapi Notre Dame, Tournai, Belgium, 6Maria Middelares Medical Centre, Ghent, Belgium, 7UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium, 8Ziekenhuis Oost Limburg, Genk, Belgium, 9Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium, 10University Hospitals Leuven, Leuven, Belgium, 11AZ Groeninge Hospital, Kortrijk, Belgium, 12AZ St Lucas, Gent, Belgium, 13Hopital Universitaire Erasme, Brussels, Belgium, 14Clinique St-Pierre, Ottignies, Belgium, 15CHU UCL Namur site Sainte Elisabeth, Brussels, Belgium, 16AZ Delta, Roeselare, Belgium, 17Hospital CHR de la Citadelle, Liège, Belgium, 18Jessa Ziekenhuis, Hasselt, Belgium, 19CHU Ambroise-Paré, Mons, Belgium, 20Takeda Pharmaceuticals, Medical Affairs, Brussels, Belgium, 21Takeda Pharmaceuticals Company, Statistics, Boston, USA, 22Takeda Pharmaceuticals, Epidemiology, London, UK

P132: Detection and monitoring of IBD based on faecal volatile organic compounds

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Bosch*1, D. Wintjens2, A. Wicaksono3, J. Kuijvenhoven4, P. Stokkers5, R. van der Hulst4, E. Daulton3, M. Pierik2, J. A. Covington3, N. K. De Boer1, T. G. de Meij6

1Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2MUMC+, Gastroenterology and Hepatology, Maastricht, The Netherlands, 3University of Warwick, School of Engineering, Coventry, UK, 4Spaarne Gasthuis, Gastroenterology and Hepatology, Hoofddorp, The Netherlands, 5OLVG West, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 6Amsterdam UMC, Pediatric gastroenterology, Amsterdam, The Netherlands

P133: Comparison of accuracy between faecal immunochemical test and faecal calprotectin for predicting mucosal healing in quiescent ulcerative colitis patients: a prospective multi-centre study

ECCO '19 Copenhagen

Year: 2019
Authors:

E. S. Kim*1, S. K. Kim1, H. S. Lee1, Y. J. Lee2, E. Y. Kim3, B. I. Jang4, K. O. Kim4, C. H. Yang5, Y-J. Lee1, E. Y. Lee1, Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD)1

1Kyungpook National University, School of Medicine, Internal Medicine, Daegu, South Korea, 2Keimyung University, School of Medicine, Internal Medicine, Daegu, South Korea, 3Catholic University of Daegu, School of Medicine, Internal Medicine, Daegu, South Korea, 4Yeungnam University College of Medicine, Internal Medicine, Daegu, South Korea, 5Dongguk University School of Medicine, Internal Medicine, Gyeongju, South Korea

P134: Long-term bowel function and fate of the ileal pouch after restorative proctocolectomy in patients with Crohn’s disease: a systematic review and meta-analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Pellino*1, D. Vinci1, G. Signoriello2, C. Kontovounisios3, S. Canonico1, F. Selvaggi1, G. Sciaudone1

1Universitá della Campania, Colorectal Surgery, Department of Medical, Surgical, Neurological, Metabolic and Ageing Sciences, Naples, Italy, 2Università della Campania Luigi Vanvitelli, Section of Statistic, Department of Mental Health and Public Medicine, Naples, Italy, 3Royal Marsden Hospital and Imperial College London, Unit of Colorectal Surgery, Royal Marsden Hospital, London, UK

P135: Altered body composition profiles in young adults with childhood-onset inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

G. V. Sigurdsson*1,2, S. Schmidt3, D. Mellström4, M. Karlsson5, M. Lorentzon6,7, R. Saalman1,2

1Queen Silvia′s Children Hospital, Gothenburg, Sweden, 2Institute of Clinical Sciences, The Sahlgrenska Academy at University of Gothenburg, Department of pediatrics, Gothenburg, Sweden, 3Premier Research LLC, Durham/NC, USA, 4Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Gothenburg, Sweden, 5Clinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences and Orthopedics, University of Lund, Malmö, Sweden, 6Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Gothenburg, Sweden, 7Sahlgrenska University Hospital, Geriatric Medicine, Gothenburg, Sweden

P136: Association between histological indices and ulcerative colitis activity measures among patients in the HICKORY (etrolizumab) open-label induction cohort

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Peyrin-Biroulet*1, B. Feagan2, R. K. Pai3, U. Arulmani4, A. Boruvka5, Y. S. Oh4, A. Scherl4, A. Scalori5, P. Arrisi5, S. Tole4, D. T. Rubin6

1Université de Lorraine, Vandœuvre-lès-Nancy (Nancy University Hospital, Lorraine University), Nancy, France, 2University of Western Ontario, London, Canada, 3Mayo Clinic, Phoenix, USA, 4Genentech, South San Francisco, USA, 5Roche, Burgess Hill, UK, 6University of Chicago Medicine, Chicago, USA

P137: Serum biomarkers of degradation and formation of type III, IV and V collagen are associated with disease activity in patients with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Domislovic*1, J. H. Mortensen2, M. A. Karsdal2, A. Barisic1, T. Manon-Jensen2, Z. Krznaric1,3,4

1Clinical Hospital Centre Zagreb, Department of Gastroenterology and Hepatology, Zagreb, Croatia, 2Nordic Bioscience A/S, Biomarkers and Research, Herlev, Denmark, 3Unit of Clinical Nutrition, University Hospital Zagreb, Zagreb, Croatia, 4University of Zagreb, School of Medicine, Zagreb, Croatia

P138: Prediction model to safely cease anti-TNF therapy in Crohn’s disease: individual patient data meta-analysis (IPD-MA)

ECCO '19 Copenhagen

Year: 2019
Authors:

R. W. M. Pauwels*1, C. J. van der Woude1, D. Nieboer2, E. W. Steyerberg2,3, M. J. Casanova4, J. P. Gisbert4, A. J. Lobo5, C. W. Lees6, N. A. Kennedy5, T. Molnár7, K. Szánto7, E. Louis8, J-Y. Mary9, M. Lukas10,11, M. Duijvestein12, S. Bots12, G. R. A. M. D'Haens12, A. C. de Vries1

1Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands, 2Erasmus MC, Department of Public Health, Rotterdam, The Netherlands, 3Leiden UMC, Department of Clinical Biostatistics and Medical Decision Making, Leiden, The Netherlands, 4Madrid Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Department of Gastroenterology, Madrid, Spain, 5Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Department of Gastroenterology and Hepatology, Sheffield, UK, 6Western General Hospital, Department of Gastroenterology and Hepatology, Edinburgh, UK, 7University of Szeged, Department of Medicine, Szeged, Hungary, 8Centre Hospitalier Universitaire de Liège, Department of Gastroenterology and Hepatology, Liège, Belgium, 9INSERM U717, Department of Biostatistics and Clinical Epidemiology, Paris, France, 10IBD Clinical and Research Centre, Iscare a.s, Prague, Czech Republic, 11Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Medical Faculty and General Teaching Hospital, Prague, Czech Republic, 12Amsterdam UMC, Academic Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

P139: Advance of medical therapies may improve outcome of ulcerative colitis with cytomegalovirus infection

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Kitamoto*1, S. Yamamoto1, M. Matsuura1, Y. Honzawa1, S. Yamada1, M. Okabe1, H. Seno1

1Graduate School of Medicine, Kyoto University, Department of Gastroenterology and Hepatology, Kyoto, Japan